articleTop 10% cited
Impact, Diagnosis and Treatment of von Willebrand Disease
Thrombosis and Haemostasis · 2000 · Vol. 84(08) · pp. 160–174
J. Evan Sadler✉Erik BerntorpН. П. БочковVictor BoulyjenkovDavid Ginsburg(Institute of Human Genetics)Dominique MeyerI. R. PeakeFrancesco RodeghieroAlok SrivastavaP.M. Mannucci(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Abstract
* Based upon the report of a joint World Health Organization/International Society on Thrombosis and Haemostasis Meeting held in London, 12-14 October 1998. Published with permission of the World Health Organization.
Platelet Disorders and TreatmentsMyeloproliferative Neoplasms: Diagnosis and TreatmentBlood groups and transfusionThrombosisMedicineVon Willebrand diseaseDiseaseIntensive care medicinePublic healthVon Willebrand factorPathologyImmunologySurgery
MeSH terms
Developing CountriesFemaleHumansMaleMass ScreeningPregnancyvon Willebrand Factorvon Willebrand DiseasesPrevalence
Citations
502
FWCI
9.67
field-weighted impact
References
179
Percentile
99%
vs. same field & year
Citations per year
Cited by
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
British Journal of Haematology · 2005 · 470 citations
References
Associations of Factor VIII and von Willebrand Factor with Age, Race, Sex, and Risk Factors for Atherosclerosis
Thrombosis and Haemostasis · 1993 · 438 citations
A Revised Classification of von Willebrand Disease
Thrombosis and Haemostasis · 1994 · 588 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.